Home Other Building Blocks 264264-32-6
264264-32-6,MFCD06797485
Catalog No.:AA002T35

264264-32-6 | 3-(5-Methyl-1,2,4-oxadiazol-3-yl)benzoic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$35.00   $25.00
- +
1g
98%
in stock  
$110.00   $77.00
- +
5g
98%
in stock  
$363.00   $254.00
- +
10g
98%
in stock  
$710.00   $497.00
- +
25g
98%
in stock  
$1,407.00   $985.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA002T35
Chemical Name:
3-(5-Methyl-1,2,4-oxadiazol-3-yl)benzoic acid
CAS Number:
264264-32-6
Molecular Formula:
C10H8N2O3
Molecular Weight:
204.1821
MDL Number:
MFCD06797485
SMILES:
Cc1onc(n1)c1cccc(c1)C(=O)O
Properties
Properties
 
BP:
428°C at 760 mmHg  
Form:
Solid  
MP:
223 °C  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
247  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
2  
XLogP3:
1.9  

Downstream Synthesis Route

[1]Mueller,G.[ChemischeBerichte,1886,vol.19,p.1497]

264264-32-6    264264-45-1   
trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine 

[1]Macdonald,GregorJ.;Branch,CliveL.;Hadley,MichaelS.;Johnson,ChristopherN.;Nash,DavidJ.;Smith,AlexanderB.;Stemp,Geoffrey;Thewlis,KevinM.;Vong,AntonioK.K.;Austin,NigelE.;Jeffrey,Phillip;Winborn,KimY.;Boyfield,Izzy;Hagan,JimJ.;Middlemiss,DerekN.;Reavill,Charlie;Riley,GrahamJ.;Watson,JeannetteM.;Wood,Martyn;Parker,SteveG.;AshbyJr.,CharlesR.[JournalofMedicinalChemistry,2003,vol.46,#23,p.4952-4964]

264264-32-6    264264-53-1   
trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyloxy-2,3,4,5-tetrahydro-1H-3-benzazepine 

[1]Macdonald,GregorJ.;Branch,CliveL.;Hadley,MichaelS.;Johnson,ChristopherN.;Nash,DavidJ.;Smith,AlexanderB.;Stemp,Geoffrey;Thewlis,KevinM.;Vong,AntonioK.K.;Austin,NigelE.;Jeffrey,Phillip;Winborn,KimY.;Boyfield,Izzy;Hagan,JimJ.;Middlemiss,DerekN.;Reavill,Charlie;Riley,GrahamJ.;Watson,JeannetteM.;Wood,Martyn;Parker,SteveG.;AshbyJr.,CharlesR.[JournalofMedicinalChemistry,2003,vol.46,#23,p.4952-4964]

873662-50-1    264264-32-6   
<i>N</i>-{4-4-(5-methoxy-benzo<i>d</i>isoxazol-3-yl)-piperazin-1-yl-butyl}-3-(5-methyl-1,2,4oxadiazol-3-yl)-benzamide 

[1]Leopoldo,Marcello;Lacivita,Enza;DeGiorgio,Paola;Colabufo,NicolaA.;Niso,Mauro;Berardi,Francesco;Perrone,Roberto[JournalofMedicinalChemistry,2006,vol.49,#1,p.358-365]

trans-3-(2-(1-(4-amino)cyclohexyl)ethyl)-7-cyano-2,3,4,5-tetrahydro-1H-3-benzazepine 
  264264-32-6   
trans-7-cyano-3-(2-(1-(4-(3-(3-(5-methyl)-1,2,4-oxadiazolyl)benzoyl)amino)cyclohexyl)ethyl)-2,3,4,5-tetrahydro-1H-3-benzazepine 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2005/94835,2005,A1Locationinpatent:Page/Pagecolumn73

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:264264-32-6 Molecular Formula|264264-32-6 MDL|264264-32-6 SMILES|264264-32-6 3-(5-Methyl-1,2,4-oxadiazol-3-yl)benzoic acid |Heterocyclic_Building_Blocks